TumorGen
Dr. Sam Kassegne holds a Ph.D. degree in engineering mechanics from Virginia Polytechnic Institute and State University. His research interests are in the areas of MEMS, especially integrated micro and nano-fabrication technologies. His experimental research work is focused primarily on Organic-MEMS, novel applications of microfluidics/nanofluidics and microarray technology, new bio-nanoelectronics platforms, as well as polymer photovoltaic technology. His lab has a strong focus on developing the next generation of integrated micro and nano-lithography technology for a variety of application areas. Other focus areas include MEMS-based IMUs.
Dr. Kassegne has extensive industrial experience in MEMS, biotech, and computational sciences acquired through his employment at Nanogen, Microfabrica, and Bentley Systems.
Dr. Kassegne and his lab have been long-standing collaborators and advisors of TumorGen and assisted in the development of the CSC3 platform.
This person is not in the org chart
This person is not in any offices
TumorGen
TumorGen is developing a novel drug discovery platform to identify unseen therapeutic targets associated with cancer metastasis. Their patented technology is used to capture circulating metastatic cancer cell clusters (MCCCs).